223 related articles for article (PubMed ID: 36475386)
21. Proteome-wide Association Study Provides Insights Into the Genetic Component of Protein Abundance in Psychiatric Disorders.
Liu J; Li X; Luo XJ
Biol Psychiatry; 2021 Dec; 90(11):781-789. PubMed ID: 34454697
[TBL] [Abstract][Full Text] [Related]
22. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
23. Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits.
Toikumo S; Xu H; Gelernter J; Kember RL; Kranzler HR
Neuropsychopharmacology; 2022 Dec; 47(13):2292-2299. PubMed ID: 35941285
[TBL] [Abstract][Full Text] [Related]
24. Identifying causal genes for migraine by integrating the proteome and transcriptome.
Li SJ; Shi JJ; Mao CY; Zhang C; Xu YF; Fan Y; Hu ZW; Yu WK; Hao XY; Li MJ; Li JD; Ma DR; Guo MN; Zuo CY; Liang YY; Xu YM; Wu J; Sun SL; Wang YG; Shi CH
J Headache Pain; 2023 Aug; 24(1):111. PubMed ID: 37592229
[TBL] [Abstract][Full Text] [Related]
25. Brain proteome-wide association study implicates novel proteins in depression pathogenesis.
Wingo TS; Liu Y; Gerasimov ES; Gockley J; Logsdon BA; Duong DM; Dammer EB; Lori A; Kim PJ; Ressler KJ; Beach TG; Reiman EM; Epstein MP; De Jager PL; Lah JJ; Bennett DA; Seyfried NT; Levey AI; Wingo AP
Nat Neurosci; 2021 Jun; 24(6):810-817. PubMed ID: 33846625
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
27. Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.
Isobe N; Keshavan A; Gourraud PA; Zhu AH; Datta E; Schlaeger R; Caillier SJ; Santaniello A; Lizée A; Himmelstein DS; Baranzini SE; Hollenbach J; Cree BA; Hauser SL; Oksenberg JR; Henry RG
JAMA Neurol; 2016 Jul; 73(7):795-802. PubMed ID: 27244296
[TBL] [Abstract][Full Text] [Related]
28. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology.
Teuber-Hanselmann S; Meinl E; Junker A
J Pathol; 2020 Apr; 250(5):496-509. PubMed ID: 32073139
[TBL] [Abstract][Full Text] [Related]
30. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.
Sanfilipo MP; Benedict RH; Weinstock-Guttman B; Bakshi R
Neurology; 2006 Mar; 66(5):685-92. PubMed ID: 16534104
[TBL] [Abstract][Full Text] [Related]
31. Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment.
Liu A; Manuel AM; Dai Y; Zhao Z
BMC Genomics; 2022 May; 23(Suppl 4):362. PubMed ID: 35545758
[TBL] [Abstract][Full Text] [Related]
32. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel functional brain proteins for treatment-resistant schizophrenia: Based on a proteome-wide association study.
Wei W; Zhang H; Cheng B; Qin X; He D; Zhang N; Zhao Y; Cai Q; Shi S; Chu X; Wen Y; Liu H; Jia Y; Zhang F
Eur Psychiatry; 2023 Apr; 66(1):e33. PubMed ID: 37055858
[TBL] [Abstract][Full Text] [Related]
34. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
35. In vivo quantitative whole-brain T1 rho MRI of multiple sclerosis.
Gonyea JV; Watts R; Applebee A; Andrews T; Hipko S; Nickerson JP; Thornton L; Filippi CG
J Magn Reson Imaging; 2015 Dec; 42(6):1623-30. PubMed ID: 26032694
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis, cannabis, and cognition: A structural MRI study.
Romero K; Pavisian B; Staines WR; Feinstein A
Neuroimage Clin; 2015; 8():140-7. PubMed ID: 26106538
[TBL] [Abstract][Full Text] [Related]
37. Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.
Newbould RD; Nicholas R; Thomas CL; Quest R; Lee JS; Honeyfield L; Colasanti A; Malik O; Mattoscio M; Matthews PM; Sormani MP; Waldman AD; Muraro PA
Neuroimage Clin; 2014; 4():641-8. PubMed ID: 24936415
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
Kalinin I; Makshakov G; Evdoshenko E
AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
[TBL] [Abstract][Full Text] [Related]
39. [Cortical gray matter lesions in multiple sclerosis].
Kawachi I; Nishizawa M
Brain Nerve; 2015 Apr; 67(4):497-504. PubMed ID: 25846598
[TBL] [Abstract][Full Text] [Related]
40. Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study.
Fuchs TA; Carolus K; Benedict RHB; Bergsland N; Ramasamy D; Jakimovski D; Weinstock-Guttman B; Kuceyeski A; Zivadinov R; Dwyer MG
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1480-1486. PubMed ID: 29976833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
